Parasym Health
Private Company
Total funding raised: $6.5M
Overview
Parasym Health is a clinical-stage neuromodulation company with a patented wearable device designed to deliver precise bioelectric signals to the vagus nerve. Its technology, backed by over $10M in R&D and 50+ clinical studies, has demonstrated proof-of-concept in areas including cardiac arrhythmia, learning enhancement, and immune modulation. The company operates a B2B and direct-to-consumer model, partnering with over 100 elite research institutions and targeting a broad market spanning healthcare, sports performance, and defense.
Technology Platform
Patented wearable device for non-invasive, transcutaneous vagus nerve stimulation (tVNS) designed to deliver precise bioelectric signals to modulate the autonomic nervous system and achieve therapeutic benefits.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
In medical tVNS, competitors include electroCore (gammaCore) and other non-invasive stimulators. In the implantable VNS space, LivaNova is a leader. The broader wellness neuromodulation market is fragmented with many consumer-grade devices (e.g., for sleep, focus) with varying levels of clinical support. Parasym differentiates with its depth of clinical data and focus on precise neural targeting.